Back to Trials
NCT05899023NARecruiting

ED Diabetes Screening and Outpatient Care - Aim 3

NYU Langone Health

Start Date

12/1/2025

Completion Date

5/31/2028

Summary

This goal of this NIH funded R01 study is to identify risk factors for not being able to follow-up for a new diagnosis of diabetes in the emergency department and improve linkage of these newly diagnosed patients to appropriate outpatient care. Its three aims will be accomplished through 1) a retrospective chart review of emergency department (ED) patients screened for diabetes, 2) a series of prospective qualitative interviews among ED patients with newly diagnosed diabetes who fail to follow-up for outpatient care, and 3) a simple randomized controlled trial to test the efficacy of telehealth bridge visits to connect ED patients with newly diagnosed diabetes to outpatient primary care.

Eligibility Criteria

Age Range: 20 years to 70 years

Inclusion Criteria: * Emergency patient receiving lab tests with an initial HbA1c test result of ≥ 6.5% * Residential address in New York City or Long Island * Primary language is English or Spanish * Able to provide informed consent Exclusion Criteria: * No prior history of diabetes * No medical condition that would result in a spurious HbA1c test (e.g., sickle cell, recent blood loss)

Interventions

OTHER

Telehealth Bridge Visits

OTHER

Standard of Care

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Diabetes MellitusNon Insulin Dependent Diabetes Mellitus

Locations

NYU Langone Health

New York, New York 10016

United States